Cardiovascular

02 – Cardiovascular

Wiltshire BSW STP Antiplatelets Summary (GWH & RUH pts only)


Wiltshire INR self-testing & self-monitoring


Wiltshire Sacubitril Valsartan for Heart Failure


Wiltshire Monoclonal antibodies for lowering cholesterol – Prescribing advice


Wiltshire Omega-3 - advisory summary


Wiltshire How should conversion between doxazosin formulations be carried out in patients with hypertension


Wiltshire Diltiazem Dosing Regimes


Wiltshire Compression and Lymphoedema Garments


NICE Hypertension Guidance


NICE Hypertension Guidance – Patient Decision Aid


Direct Oral Anticoagulants (DOACs – formerly NOACs)

BSW Guidance on converting between anticoagulants


BSW PrescQIPP Atrial fibrillation: Patient information and decision aid


BSW PrescQIPP Prescriber decision support - Warfarin


BSW PrescQIPP Patient information - Non-vitamin K antagonist oral anticoagulants (NOACs)


BSW PrescQIPP Comparison of novel oral anticoagulants (NOACs)


BSW PrescQIPP Drug interactions with NOACs


BSW PrescQIPP Considerations for anticoagulationin Venous Thrombo-embolism (VTE)


BSW Direct Oral Anticoagulants (DOACs) for DVT and PE in adults: Local pathways


BSW PrescQIPP Anticoagulation Bulletin


BSW PrescQIPP Anticoagulation Briefing


Statins

Wiltshire Management of Lipids in Primary Care